Keryx Biopharmaceuticals (KERX) March straddle price suggests wide price risk

February 20, 2008 7:27 AM EST Send to a Friend
Keryx Biopharmaceuticals (Nasdaq: KERX) : KERX lead compound, Sulonex (sulodexide oral gelcap) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login